Akari Therapeutics Plc (AKTX) Insider Trading

Name: Akari Therapeutics Plc (AKTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 1, 2026): Gaslightwala Abizer (CEO): Grant/Award of 6,430 shares, $62.5K.

Get alerted when insiders trade AKTX

Email address

Loading company data...

Beta

Loading company details...

Beta